看见一个 Expert Review of Anticancer Therapy。你们前面用依维莫斯,血、肝肾功能还好。下一步是否考虑索拉非尼+依维莫斯。供你参考。
$ D- x) o! q. c2 V
. [* Y! H* ]' C4 ~- O# u8 L
/ W- J- E% N: h9 b5 T) m8 xCurrently available feasibility data for possible combination strategies.
; M$ i) W9 w6 ~1 Z. f7 i+ N————————————————————————————————# F+ \" @2 Z$ B+ w0 f7 h
Combination Feasibility according to preliminary data * _1 O8 ?+ H }3 H! d
——————————————————————————————————
; j9 [, f5 m# t( X$ _Bevacizumab + sorafenib Yes, reduced dose
8 J& x# H7 \* w1 B, }Bevacizumab + sunitinib† No ! e" T& W! b, e Z7 @0 h
Bevacizumab + temsirolimus Yes
/ K+ r3 f& F( y! @$ w6 i$ hBevacizumab + everolimus Yes
+ I2 C% Y- H+ s% b0 ESorafenib + sunitinib ? 3 g8 u: H* w# k6 Q! O0 J6 n
Sorafenib + temsirolimus Yes, reduced dose
) [- q5 ?6 g& a7 vSorafenib + everolimus Yes, reduced dose ) a! p2 [$ J. [! u( Y
Sunitinib + temsirolimus† No - C7 @+ O8 S. C9 i/ t
Sunitinib + everolimus ? % N0 N# e, w$ ]
Temsirolimus + everolimus ? O1 H4 N9 z# D5 v/ q
————————————————————
# r& t. w1 ?/ I$ z' C' p& W†Led to US FDA warning.
+ |4 S: J$ h' @?: As yet unattempted combination.
8 L1 j5 M% F. p: p. z& Z |